News NP Inc.

Equities

A291230

KR7291230001

End-of-day quote Korea S.E. Other stock markets 03:30:00 29/04/2024 am IST			5-day change	1st Jan Change
2,720 ^KRW	+2.84%		-0.18%	-16.31%

03/04	Ultra Lithium Provides Bi-Weekly Default Status Report	MT
29/03	Shanaya’s Subsidiary Enters MOU with Ngee Ann Polytechnic; Shares Surge 10%	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Ultra Lithium Provides Bi-Weekly Default Status Report	03/04	MT
Shanaya’s Subsidiary Enters MOU with Ngee Ann Polytechnic; Shares Surge 10%	29/03	MT
Algernon Pharmaceuticals Says Acquisition of Ifenprodil Program Completed by US Company	27/03	MT
Down 17%, BioVaxys Technology Corp. Provides Bi-Weekly MCTO Status Update	08/03	MT
MCF Energy Acquired "Accretive" Czech Gas Projects With "Immediate Production And Growth Potential"	27/02	MT
MCF Energy Acquires Accretive Czech Gas Projects with Immediate Production and Growth Potential	26/02	MT
Vizsla Silver Up 0.75% In US Premarket After Reporting Additional High Grade Intercepts at La Luisa	13/02	MT
Algernon Pharmaceuticals Receives Notice of Intention to Grant from Chinese Patent Office for Repirinast to Treat CKD	31/01	MT
Algernon Pharmaceuticals Receives Notice of Intention to Grant from Chinese Patent Office for Repirinast	30/11	MT
Algernon Pharma in LOI For Acquisition of its Chronic Cough Research Program For US$2 Million and 20% Equity Stake	22/11	MT
Aehr Test Systems Receives Initial Order From Unnamed New Customer for Wafer Level Test, Burn-in Systems	18/23/18	MT
Algernon Pharmaceuticals Announces Grant of U.S. Patent for Repirinast in NAFLD and NASH	06/23/06	MT
Novelplus Technology Trims Loss in H1	15/23/15	MT
Napo Pharmaceuticals Submits Funding Application to BARDA for NP-300 Development	09/23/09	MT
Moody's Withdraws Ratings on Austria's Addiko Bank	09/23/09	MT
Algernon Pharmaceuticals Engage Maxim Group to Explore Spin-Off of Ifenprodil Phase 2 Chronic Cough Drug Development Program	27/23/27	MT
Algernon Pharmaceuticals Receives Notice of Allowance From Japanese Patent Office for Repirinast and Treatment of CKD	31/23/31	MT
Vizsla Silver Up More Than 6% In US Pre-Market On Extending High Grade Mineralization at La Luisa and Defining New Exploration Targe to the North	30/23/30	MT
NP Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	12/23/12	CI
Former UN chief Ban returns to Myanmar, meets ruling general	24/23/24	RE

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News NP Inc.

Equities

A291230

KR7291230001

Summary

Filters